Total Payments
$14,116
2024 Payments
$2,579
Companies
37
Transactions
865
Medicare Patients
2,262
Medicare Billing
$559,411
Payment Breakdown by Category
Food & Beverage$13,650 (96.7%)
Education$266.14 (1.9%)
Consulting$200.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,650 | 858 | 96.7% |
| Education | $266.14 | 6 | 1.9% |
| Consulting Fee | $200.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,561 | 145 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,508 | 96 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,277 | 72 | $0 (2024) |
| Alkermes, Inc. | $1,164 | 58 | $0 (2024) |
| ABBVIE INC. | $1,014 | 78 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $916.77 | 79 | $0 (2024) |
| Lundbeck LLC | $722.61 | 44 | $0 (2024) |
| ITI, Inc. | $490.60 | 27 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $457.70 | 26 | $0 (2024) |
| Allergan, Inc. | $447.37 | 33 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,579 | 124 | Teva Pharmaceuticals USA, Inc. ($365.90) |
| 2023 | $2,106 | 123 | Teva Pharmaceuticals USA, Inc. ($342.79) |
| 2022 | $1,900 | 116 | Janssen Pharmaceuticals, Inc ($461.68) |
| 2021 | $2,084 | 143 | Janssen Pharmaceuticals, Inc ($472.94) |
| 2020 | $1,592 | 112 | Otsuka America Pharmaceutical, Inc. ($257.34) |
| 2019 | $1,473 | 97 | Otsuka America Pharmaceutical, Inc. ($395.51) |
| 2018 | $1,232 | 81 | Otsuka America Pharmaceutical, Inc. ($210.45) |
| 2017 | $1,149 | 69 | Otsuka America Pharmaceutical, Inc. ($287.02) |
All Payment Transactions
865 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: CNS | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: CNS | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: CNS | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: CNS | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 421 | 1,538 | $321,325 | $122,872 |
| 2022 | 3 | 576 | 2,084 | $335,350 | $141,717 |
| 2021 | 3 | 726 | 2,402 | $357,950 | $168,192 |
| 2020 | 2 | 539 | 2,908 | $302,400 | $126,630 |
Total Patients
2,262
Total Services
8,932
Medicare Billing
$559,411
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 1,228 | $246,200 | $87,756 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 229 | $62,975 | $31,209 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 81 | $12,150 | $3,907 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 424 | 1,852 | $296,050 | $127,086 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 167 | $18,700 | $8,235 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $20,600 | $6,396 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 448 | 2,068 | $310,100 | $153,595 | 49.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 72 | 72 | $21,600 | $7,430 | 34.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 262 | $26,250 | $7,167 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 481 | 2,850 | $285,000 | $121,305 | 42.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 58 | 58 | $17,400 | $5,324 | 30.6% |
About Dr. Ilan Levinson, MD
Dr. Ilan Levinson, MD is a Psychiatry healthcare provider based in Stroudsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982625000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilan Levinson, MD has received a total of $14,116 in payments from pharmaceutical and medical device companies, with $2,579 received in 2024. These payments were reported across 865 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($13,650).
As a Medicare-enrolled provider, Levinson has provided services to 2,262 Medicare beneficiaries, totaling 8,932 services with total Medicare billing of $559,411. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Stroudsburg, PA
- Active Since 07/22/2006
- Last Updated 10/15/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982625000
Products in Payments
- INVEGA SUSTENNA (Drug) $1,540
- VRAYLAR (Drug) $1,462
- REXULTI (Drug) $1,407
- SPRAVATO (Drug) $1,066
- TRINTELLIX (Drug) $865.11
- ARISTADA (Drug) $788.27
- AUSTEDO (Drug) $770.63
- CAPLYTA (Drug) $731.15
- ABILIFY MAINTENA (Drug) $623.02
- INGREZZA (Drug) $457.70
- LATUDA (Drug) $367.17
- QELBREE (Drug) $300.43
- Auvelity (Drug) $276.58
- Trintellix (Drug) $271.37
- UZEDY (Drug) $215.12
- VYVANSE (Drug) $172.81
- VIVITROL (Drug) $171.37
- Fanapt (Drug) $164.98
- HETLIOZ (Drug) $159.90
- Austedo XR (Drug) $154.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.